Product Information
VALSARTAN 160 MG TABLET is a generic product labeled by Ohm Laboratories Inc., priced at $0.1060 per EA under NDC 51660014290. Its NADAC has been published 618 times since Sep 17, 2014.
FDA first approved this application on Jun 26, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
160 mg/1
Manufacturer
Ohm Laboratories Inc.NDC
51660014290
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA077492FDA Approved
6/26/2014
TE Code
AB
On Market Since
7/7/2014
Pharmacological Classes
Price Statistics
The NADAC for VALSARTAN 160 MG TABLET has been published 618 times since Sep 17, 2014, and over the history we have for it it has declined 96.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1060 per EA |
|---|---|
| All-time high | $3.3552 (Oct 15, 2014) |
| All-time low | $0.0929 (Jan 17, 2018) |
| 52-week high | $0.1462 |
| 52-week low | $0.1060 |
| Median price | $0.2281 |
| Average price | $0.3671 |
| Largest weekly change | +116.9% (Oct 17, 2018) |
| Weeks tracked | 618 |
| Tracking since | Sep 17, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the VALSARTAN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ohm Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
VALSARTAN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALSARTAN 160 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN 160 MG TABLET, manufactured by Ohm Laboratories Inc., is $0.1060 per EA (NDC 51660014290), effective Sep 30, 2026.
How has the price of VALSARTAN 160 MG TABLET changed over time?
Over the history we have for it, the NADAC for VALSARTAN 160 MG TABLET has declined 96.8%. It has been tracked across 618 weekly CMS publications since Sep 17, 2014.
What are the highest and lowest recorded NADAC prices for VALSARTAN 160 MG TABLET?
Since Sep 17, 2014, the NADAC for VALSARTAN 160 MG TABLET has ranged from a low of $0.0929 (Jan 17, 2018) to a high of $3.3552 (Oct 15, 2014), with a median of $0.2281 per EA.
Are there cheaper alternatives to VALSARTAN 160 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of VALSARTAN 160 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VALSARTAN 160 MG TABLET?
VALSARTAN 160 MG TABLET (NDC 51660014290) is labeled by Ohm Laboratories Inc., and CMS classifies it as a generic product.